New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ: SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the "Class Period"), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If you purchased Synopsys securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK , Nov. 17, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline. So what: If you purchased MoonLake common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the "Class Period"), of the important November 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased Jasper Therapeutics securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

SAN FRANCISCO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- On November 5, 2025, investors in Zimmer Biomet Holdings, Inc. (NYSE: ZBH) saw the price of their shares tumble $15.63 (-15%) after the company announced its Q3 2025 financial results and revealed cancelation of emerging markets distributor orders, prompting one analyst to question management's guidance philosophy.

Warren Buffett's Berkshire Hathaway is making a big bet on one of the hottest tech stocks.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”), of the important December 15, 2025 lead plaintiff deadline.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline.

New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.

New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CarMax, Inc. (NYSE: KMX) between June 20, 2025 and November 5, 2025, both dates inclusive (the "Class Period") of the important January 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased CarMax securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Proficient Auto Logistics reported decent third quarter results with revenues well ahead of consensus expectations and strong cash generation. Management raised full-year revenue expectations but warned of overcapacities and resulting pricing pressure which have impacted the company's ability to win new business at sufficient margins. As near-term prospects have become more uncertain as of late, I have reduced my profitability estimates and lowered my price target from $18 to $13.

New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important December 29, 2025 lead plaintiff deadline. SO WHAT: If you purchased Avantor common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Australia's remote Indian Ocean outpost of Christmas Island has enough power to support a new Google data centre without depriving locals, but its arrival could spur a push to renewable energy, the island's biggest employer and the tech giant said.

India's merchandise trade deficit hit an all-time high of $41.7 billion in October. India imported gold worth of $14.7 billion, up nearly 200% from October last year.

Equifax said Monday (Nov. 17) that it acquired Vault Verify, a company that offers services that include employment and income verification. This acquisition enhances the data that Equifax already provides to verifiers and provides another mechanism for employers to provide data to a verifications provider, Equifax said in a Monday press release.

Equinox Gold remains a Strong Buy, supported by robust fundamentals, significant production growth in the near term, and an attractive valuation versus peers. Q3 results exceeded expectations, with significant EPS and revenue beats, and 2025 marks an inflection point as production ramps up. EQX's growth pipeline is strong, with successful integration of Calibre assets, debt reduction, and potential for further M&A or even being an acquisition target.

LifeMD, Inc. ( LFMD ) Q3 2025 Earnings Call November 17, 2025 4:30 PM EST Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG, LLC, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Anderson Schock - B. Riley Securities, Inc., Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Eduardo Martinez-Montes - H.C.

iShares U.S. Equity Factor ETF is a large-cap blend ETF aiming to optimize exposure to the quality, value, momentum, size, and low volatility factors. Its ER is 0.08%, and LRGF has $3B in AUM. LRGF has tracked the STOXX U.S. Equity Factor Index since June 2022, and since this strategy change, it's been solid, outperforming SPY and IWB over the last three years. The reason is because LRGF is one of the few "sensible" multi-factor ETFs out there. My in-depth analysis walks readers through each factor one-by-one by emphasizing dozens of underlying statistics.

It's been hard to overlook Walmart's (WMT) steady growth, while Target's (TGT) cheaper valuation may still compel investors as a potential buy-the-dip target.

MONTRÉAL, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Air Canada unveiled its 2025 Top 10 Best New Restaurants in Canada today at a Toronto celebration, with Halifax restaurant Mystic earning first-place honours. Led by Chef Malcolm Campbell and his team, Mystic's immersive tasting menus marry local Maritime terroir with global technique in a beautiful waterfront setting.

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 12, 2026.